WallStreetZenWallStreetZen

NASDAQ: LUCD
Lucid Diagnostics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LUCD past revenue growth

How has LUCD's revenue growth performed historically?
Company
544.03%
Industry
9.25%
Market
17.15%
LUCD's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LUCD's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LUCD's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LUCD earnings and revenue history

Current Revenue
$2.4M
Current Earnings
-$52.7M
Current Profit Margin
-2,169.1%

LUCD Return on Equity

Current Company
-523.8%
Current Industry
10.5%
Current Market
188%
LUCD's Return on Equity (-523.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LUCD announces earnings.

LUCD Return on Assets

Current Company
-138.5%
Current Industry
5.3%
LUCD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LUCD Return on Capital Employed

Current Company
2,473.96%
Current Industry
8.3%
LUCD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LUCD vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LUCD$2.43M-$49.75M-$52.67M+120.36%N/A
CUTR$230.18M-$94.79M-$113.39M+6.90%N/A
RPID$22.52M-$52.34M-$52.47M+8.07%N/A
PXDT$5.75M-$13.79M-$15.18M+33.98%N/A
LNSR$42.16M-$10.33M-$14.38M+11.57%N/A
View Top Medical Device Stocks

LUCD earnings dates

Next earnings date
May 8, 2024

Lucid Diagnostics Earnings & Revenue FAQ

What were LUCD's earnings last quarter?

On Invalid Date, Lucid Diagnostics (NASDAQ: LUCD) reported Q4 2023 earnings per share (EPS) of -$0.25, up 37.5% year over year. Total Lucid Diagnostics earnings for the quarter were -$10.83 million. In the same quarter last year, Lucid Diagnostics's earnings per share (EPS) was -$0.40.

If you're new to stock investing, here's how to buy Lucid Diagnostics stock.

What was LUCD's earnings growth in the past year?

As of Q2 2024, Lucid Diagnostics's earnings has grown year over year. Lucid Diagnostics's earnings in the past year totalled -$52.67 million.

What is LUCD's earnings date?

Lucid Diagnostics's earnings date is Invalid Date. Add LUCD to your watchlist to be reminded of LUCD's next earnings announcement.

What was LUCD's revenue last quarter?

On Invalid Date, Lucid Diagnostics (NASDAQ: LUCD) reported Q4 2023 revenue of $1.04 million up 828.57% year over year. In the same quarter last year, Lucid Diagnostics's revenue was $112.00 thousand.

What was LUCD's revenue growth in the past year?

As of Q2 2024, Lucid Diagnostics's revenue has grown 544.03% year over year. This is 534.78 percentage points higher than the US Medical Devices industry revenue growth rate of 9.25%. Lucid Diagnostics's revenue in the past year totalled $2.43 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.